Cisplatin therapy in infants: short and long-term morbidity.
about
Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.Outcome after reduced chemotherapy for intermediate-risk neuroblastomaPhase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors.Auditory late effects of childhood cancer therapy: a report from the Children's Oncology GroupOtotoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group.Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
P2860
Cisplatin therapy in infants: short and long-term morbidity.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Cisplatin therapy in infants: short and long-term morbidity.
@ast
Cisplatin therapy in infants: short and long-term morbidity.
@en
type
label
Cisplatin therapy in infants: short and long-term morbidity.
@ast
Cisplatin therapy in infants: short and long-term morbidity.
@en
prefLabel
Cisplatin therapy in infants: short and long-term morbidity.
@ast
Cisplatin therapy in infants: short and long-term morbidity.
@en
P2093
P2860
P1476
Cisplatin therapy in infants: short and long-term morbidity.
@en
P2093
E C Yeomans
J Pritchard
S C Bellman
P2860
P304
P577
1992-08-01T00:00:00Z